Francesca Barone

2023

In 2023, Francesca Barone earned a total compensation of $706.9K as Chief Scientific Officer at Candel Therapeutics, a 22% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$80,560
Option Awards$89,577
Salary$413,005
Stock Awards$110,534
Other$13,200
Total$706,876

Barone received $413K in salary, accounting for 58% of the total pay in 2023.

Barone also received $80.6K in non-equity incentive plan, $89.6K in option awards, $110.5K in stock awards and $13.2K in other compensation.

Rankings

In 2023, Francesca Barone's compensation ranked 1,543rd out of 2,773 executives tracked by ExecPay. In other words, Barone earned more than 44.4% of executives.

ClassificationRankingPercentile
All
1,543
out of 2,773
44th
Division
Manufacturing
911
out of 1,516
40th
Major group
Chemicals And Allied Products
585
out of 855
32nd
Industry group
Drugs
569
out of 821
31st
Industry
Biological Products, Except Diagnostic Substances
158
out of 204
23rd
Source: SEC filing on May 30, 2024.

Barone's colleagues

We found two more compensation records of executives who worked with Francesca Barone at Candel Therapeutics in 2023.

2023

Paul FMedSci

Candel Therapeutics

Chief Executive Officer

2023

Jason Amello

Candel Therapeutics

Chief Financial Officer

News

You may also like